SB

Shubham Babasaheb Kusalkar

Active Director Director DIN 08662177
DIN 08662177 First appointment Jan 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Babasaheb Kusalkar

Data last updated:

Shubham Babasaheb Kusalkar is a Director at Curae Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare.

DIN 08662177
Primary Designation Director
Industry Healthcare
First Appointment 08 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20202020Active

Board colleagues of Shubham Babasaheb Kusalkar

NameDINCompanyDesignation
Dinesh Narayan Shinde08091771Curae Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curae Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shubham Babasaheb Kusalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Babasaheb Kusalkar

Shubham Babasaheb Kusalkar currently holds 1 directorship: Curae Pharmaceuticals Private Limited (Director, since 08 Jan 2020).

Shubham Babasaheb Kusalkar was first appointed on 08 Jan 2020 as Director at Curae Pharmaceuticals Private Limited.

The current boards of Shubham Babasaheb Kusalkar's companies include Dinesh Narayan Shinde (Curae Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available